TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Delegation of diagnostic tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of vitamin status in the serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of high-intensity albuterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric intensive care unit length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Eccentric hamstring impulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CMJ height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum concentration of sildenafil (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC0‐t) values of sildenafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in motor functions of the affected upper limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety disorder improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: coping strategies improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: completed 7-day follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cumulative PI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean score on the PUSH tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sensitivity of pneumothorax detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality or therapeutic failure
Endpoint domain: Mortality/survival
Primary endpoint: Change in galectin-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eliciting dose of ≥1000 mg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increased eliciting dose compared with baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tolerated full food challenge of 5444 mg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Remission from AUD or depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iron uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic yield of IOC vs MRCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFDI-20 improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Grade III or higher complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Left ventricular (LV) function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ALBI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Use of active surveillance for low-risk prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accumulation of Tregs in NPC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to the start of gait training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Risk of invasive epithelial ovarian and tubal cancer
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive performance enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Return of spontaneous circulation (ROSC) at hospital handover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival to 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Favourable neurological outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Urea-to-creatinine ratio trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average wound healing duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative ambulation and discharge time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBI
Endpoint domain: Life impact
Endpoint subdomain: Activities of daily living
Primary endpoint: Proportion of recommendations supported by high-quality evidence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of recommendations supported by moderate-quality evidence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain scores at 8 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with disease flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HSS knee scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CAPS-IV symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of OPA geometric mean titers (GMTs) at Day 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in proportions of participants with ?4-fold rise from prevaccination to Day 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of complex regional pain syndrome (CRPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: placental FATP2 and FATP3 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: neonatal sum of skinfolds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Viral load changes from baseline at Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: COVID‐19 symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Satisfaction with health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in SOFA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of shock reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall ADR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Advanced ADR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ADR of expert endoscopists
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in total FSFI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity data agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: defoaming rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual clarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decreased level of Ang II
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Increased level of NO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in delusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy and safety of dapagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement in Fibromyalgia Impact Questionnaire (FIQ) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: oxygen saturation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Genotype frequency distributions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for supervised exercise programs
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Need for earlier introduction of exercise in care pathway
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Supported referral to exercise programming
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diameter of colorectal hamartoma polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median size of perirenal hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acrosomal enzyme activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Variability in adjuvant radiotherapy recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to sleep onset (sleep latency)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of slow-wave sleep (N3 sleep)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apnea/hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Parental sense of competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in total carotid plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Improved accessibility to specialist care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: requirement for oxygen therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of successful extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of unplanned extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients alive and free of mechanical ventilation on day 15
Endpoint domain: Mortality/survival
Primary endpoint: FC response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-rated swallowing function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Daily hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Light PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: B vitamin status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of staff trained and delivering workshops
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of WHC content
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cost of implementing WHC per attendee
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Conclusive visibility of nasogastric tube positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacies not dispensing buprenorphine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Illness severity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major AF-related cardiovascular, neurological, and bleeding events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feelings of intoxication
Endpoint domain: Adverse events/effects
Primary endpoint: Overall observed POI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Motor Score (LEMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean reductions in plaque scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of oxygen-desaturation episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of apnea episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median time to the first hypoxia episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: proportion of subjects with detectable viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in BMI-for-age Z-score of first child
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in BMI-for-age Z-score of second child
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC0-48 and AUC0-72
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative hearing function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative and long-term complications
Endpoint domain: Adverse events/effects
Primary endpoint: Surgeons' feedback on views of anatomy and pathology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete response (CR) and CR with incomplete count recovery (CRi) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal residual disease < 0.01%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 SOS after hematopoietic stem-cell transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of serum eNOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: in-hospital major adverse cardiac events
Endpoint domain: Adverse events/effects
Primary endpoint: urine staining intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Younger age at starting smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net adverse clinical events (NACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-oriented composite endpoints (POCE)
Endpoint domain: Adverse events/effects
Primary endpoint: BARC-defined bleeding Type 3 or 5
Endpoint domain: Adverse events/effects
Primary endpoint: Global EEG power in the alpha frequency band during NREM sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum DHEA-S levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Perceived rate of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CSF NFL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: processing speed and executive function performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: pain-sensitive areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rates of adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in somatic symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incontinence-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incident heart failure (HF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful drop instillation in the eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in throat pain VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in LPR–HRQL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean serum levels of trace elements (Ti, Al, V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering of UACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Lowering of systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myofascial trigger point pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bladder base displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in labor time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shorter time of dissipation of acute pulmonary exudative lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: shorter time to negative conversion of viral nucleic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher rate of increase in CD4+T cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: obstruction's recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for new TB
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Failure to pass the gestational sac within 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for surgical intervention to resolve miscarriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cost per woman
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Motor Threshold increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gavage intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for rescue analgesic
Endpoint domain: Adverse events/effects
Primary endpoint: Local or systemic complications or side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Mean scores on the H&P 360 content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of hip osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain score during esophageal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopist's overall satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: functional outcome (modified Rankin Scale score, 0‐2)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pathologic or sustained clinical complete tumor response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: near-complete or complete tumor regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥3 acute toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Disabling stroke or death at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: mRS greater than 1 at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRS 0 or 1 at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between ASDAS and SASDAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year cumulative incidence rate of myopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean myopic shift in SE refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire for the next meal
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postoperative HOMA-IR index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Neonatal glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Zinc Concentration (PZC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FADS1 activity indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Annual failure rate (AFR)
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of adhesive failure
Endpoint domain: Adverse events/effects
Primary endpoint: Three-dose efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median percent reduction in Ox24 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with a decrease in Ox24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day risk of death or renal replacement therapy
Endpoint domain: Mortality/survival
Primary endpoint: 1-year risk of all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in axial motor MDS-UPDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes